Inventor
LIFSHITZ REVITAL
IL11 patents
Patents
11 patentsUS6605636B2Aug 12, 2003
Atorvastatin hemi-calcium form VII
TEVA PHARMA55 citations95
US6528661B2Mar 4, 2003
Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
TEVA PHARMA64 citations93
US6992194B2Jan 31, 2006
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA16 citations92
US6767913B2Jul 27, 2004
Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
TEVA PHARMA46 citations89
US7411075B1Aug 12, 2008
Polymorphic form of atorvastatin calcium
TEVA PHARMA14 citations87
US7144916B2Dec 5, 2006
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA7 citations81
US7342120B2Mar 11, 2008
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA6 citations73
US6201148B1Mar 13, 2001
Process for preparing alendronic acid
TEVA PHARMA13 citations73
US7468444B2Dec 23, 2008
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA1 citations62
US7488750B2Feb 10, 2009
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA0 citations51
US7732623B2Jun 8, 2010
Polymorphic form of atorvastatin calcium
TEVA PHARMA0 citations47